Pharmacists Could Factor In OTC Switch Studies - CRO Exec
This article was originally published in The Tan Sheet
Executive Summary
The involvement of pharmacists in Rx-to-OTC switch studies could be an asset to pharmaceutical companies, Synergy Health Care Pharmacy & Provider Program Director Bob Beckley told the NACDS Pharmacy, Managed Care & Technology Conference in San Diego Aug. 27.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning